These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23346412)

  • 41. Anti-BP180 Autoantibodies Are Present in Stroke and Recognize Human Cutaneous BP180 and BP180-NC16A.
    Wang Y; Mao X; Wang D; Hammers CM; Payne AS; Wang Y; Jin H; Peng B; Li L
    Front Immunol; 2019; 10():236. PubMed ID: 30863396
    [No Abstract]   [Full Text] [Related]  

  • 42. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
    van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
    JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230).
    Ghohestani RF; Cozzani E; Delaporte E; Nicolas JF; Parodi A; Claudy A
    J Clin Immunol; 1998 May; 18(3):202-9. PubMed ID: 9624579
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology.
    van Beek N; Krüger S; Fuhrmann T; Lemcke S; Goletz S; Probst C; Komorowski L; Di Zenzo G; Dmochowski M; Drenovska K; Horn M; Jedlickova H; Kowalewski C; Medenica L; Murrell D; Patsatsi A; Geller S; Uzun S; Vassileva S; Zhu X; Fechner K; Zillikens D; Stöcker W; Schmidt E; Rentzsch K
    J Am Acad Dermatol; 2020 Nov; 83(5):1315-1322. PubMed ID: 32004645
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared.
    Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D;
    Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IgE-mediated mechanisms in bullous pemphigoid and other autoimmune bullous diseases.
    van Beek N; Schulze FS; Zillikens D; Schmidt E
    Expert Rev Clin Immunol; 2016; 12(3):267-77. PubMed ID: 26588556
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors.
    Izumi K; Nishie W; Beniko M; Shimizu H
    Front Immunol; 2019; 10():1439. PubMed ID: 31297116
    [No Abstract]   [Full Text] [Related]  

  • 49. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
    Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
    Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.
    Bernard P; Antonicelli F; Bedane C; Joly P; Le Roux-Villet C; Duvert-Lehembre S; Rousselle P; Prost-Squarcioni C
    JAMA Dermatol; 2013 May; 149(5):533-40. PubMed ID: 23426192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bullous pemphigoid: serum antibody titre and antigen specificity.
    Pas HH; de Jong MC; Jonkman MF; Heeres K; Slijper-Pal IJ; van der Meer JB
    Exp Dermatol; 1995 Dec; 4(6):372-6. PubMed ID: 8608345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
    Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
    Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of the autoimmune response against BP180 and BP230 in ethnic Poles with neurodegenerative disorders and bullous pemphigoid.
    Gornowicz-Porowska J; Seraszek-Jaros A; Bowszyc-Dmochowska M; Kaczmarek E; Pietkiewicz P; Bartkiewicz P; Dmochowski M
    Cent Eur J Immunol; 2017; 42(1):85-90. PubMed ID: 28680335
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
    Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
    J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
    Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
    Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid.
    Cole C; Borradori L; Amber KT
    Antibodies (Basel); 2022 Jun; 11(3):. PubMed ID: 35892704
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease.
    Kokkonen N; Herukka SK; Huilaja L; Kokki M; Koivisto AM; Hartikainen P; Remes AM; Tasanen K
    J Invest Dermatol; 2017 Jan; 137(1):71-76. PubMed ID: 27650606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human amnion membrane as a substrate for the detection of autoantibodies in pemphigus vulgaris and bullous pemphigoid.
    Sezin T; Avitan-Hersh E; Indelman M; Moscona R; Sabo E; Katz R; Pollack S; Bergman R
    Isr Med Assoc J; 2014 Apr; 16(4):217-23. PubMed ID: 24834757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of IgE autoantibodies to BP180 and BP230 and their relationship to clinical features in bullous pemphigoid.
    Hashimoto T; Ohzono A; Teye K; Numata S; Hiroyasu S; Tsuruta D; Hachiya T; Kuroda K; Hashiguchi M; Kawakami T; Ishii N
    Br J Dermatol; 2017 Jul; 177(1):141-151. PubMed ID: 27716903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.